Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Bone Marrow Transplantation – Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T...

Skip Nav Destination Current Issue Volume 2022, Issue 1, December 9 2022...

The Multiple Myeloma Hub summarizes data from the IFM 2017-03 trial, presented at ASH 2022, exploring the efficacy and safety of dexamethasone alongside lenalidomide...

Rashmi Kanagal-Shamanna, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of novel technologies...

The panel discusses combination therapy options for patients with DLBCL and...

Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM, University College London Hospitals NHS Foundation Trust, London, UK, comments on patient...

Results from two presentations at the 64th American Society of Hematology (ASH) Annual Meeting oral abstracts session reported key data around novel combinations for...

The panel discusses regulatory hurdles and patient access considerations for non-Hodgkin lymphoma...

April 28-29, 2023 S√£o Paulo, Brazil Join the world’s leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights...

  • 1621584687515815937 Profile photo of Madelyn
    ASH

    Acomp√°√Īenos en S√£o Paulo para Highlights of ASH en Am√©rica Latina y forme conexiones con profesionales de #hematolog√≠a en la regi√≥n ūüĆćūü•ľ Reg√≠strese hoy para un resumen de la ciencia m√°s destacada de #ASH22: https://t.co/VE3FjVhtgn https://t.co/VE3FjVhtgn - view on twitter

A new method to detect minimal residual disease (MRD) in peripheral blood had an ‚Äúunprecedented sensitivity‚ÄĚ level of 10‚ąí8 in samples from patients with...